Cargando…
Selective Spectrum Antibiotic Modulation of the Gut Microbiome in Obesity and Diabetes Rodent Models
The gastrointestinal tract microbiome has been suggested as a potential therapeutic target for metabolic diseases such as obesity and Type 2 diabetes mellitus (T2DM). However, the relationship between changes in microbial communities and metabolic disease-phenotypes are still poorly understood. In t...
Autores principales: | Rajpal, Deepak K., Klein, Jean-Louis, Mayhew, David, Boucheron, Joyce, Spivak, Aaron T., Kumar, Vinod, Ingraham, Karen, Paulik, Mark, Chen, Lihong, Van Horn, Stephanie, Thomas, Elizabeth, Sathe, Ganesh, Livi, George P., Holmes, David J., Brown, James R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4692534/ https://www.ncbi.nlm.nih.gov/pubmed/26709835 http://dx.doi.org/10.1371/journal.pone.0145499 |
Ejemplares similares
-
Gut microbiome differences between metformin‐ and liraglutide‐treated T2DM subjects
por: Wang, Zhang, et al.
Publicado: (2017) -
The Response of the Rodent Gut Microbiome to Broad-Spectrum Antibiotics Is Different in Males and Females
por: Parodi, Gonzalo, et al.
Publicado: (2022) -
Weight and Glucose Reduction Observed with a Combination of Nutritional Agents in Rodent Models Does Not Translate to Humans in a Randomized Clinical Trial with Healthy Volunteers and Subjects with Type 2 Diabetes
por: Hodge, Rebecca J., et al.
Publicado: (2016) -
Serous macular detachment in nanophthalmos: A manifestation of pachychoroid spectrum
por: Kumar, Vinod, et al.
Publicado: (2019) -
The Production of Antibiotics Must Be Reoriented: Repositioning Old Narrow-Spectrum Antibiotics, Developing New Microbiome-Sparing Antibiotics
por: Diamantis, Sylvain, et al.
Publicado: (2022)